Showing results (21-30 of 111) with videos related to
Sort By:
Pageof 12
Cellular Microbiology|August 18, 2020
Synchronised infection identifies early rate-limiting steps in the hepatitis B virus life cycleAnindita Chakraborty, Chunkyu Ko, Christin Henning, et al.The American Journal of Pathology|December 13, 2016
Proteomic Analysis Reveals GMP Synthetase as p53 Repression Target in Liver CancerKerstin Holzer, Elisabeth Drucker, Stephanie Roessler, et al.Hepatology (Baltimore, Md.)|May 7, 2014
Modulation of miR-29 expression by α-fetoprotein is linked to the hepatocellular carcinoma epigenomeSonya Parpart, Stephanie Roessler, Fei Dong, et al.Cell Communication and Signaling : CCS|December 1, 2019
Karyopherin α2-dependent import of E2F1 and TFDP1 maintains protumorigenic stathmin expression in liver cancerElisabeth Drucker, Kerstin Holzer, Stefan Pusch, et al.Oncotarget|March 26, 2016
Cellular apoptosis susceptibility (CAS) is linked to integrin β1 and required for tumor cell migration and invasion in hepatocellular carcinoma (HCC)Juliane Winkler, Stephanie Roessler, Carsten Sticht, et al.Journal of Experimental & Clinical Cancer Research : CR|September 6, 2024
Membrane RRM2-positive cells represent a malignant population with cancer stem cell features in intrahepatic cholangiocarcinomaYongzhi Zhao, Shuting Xue, Danduo Wei, et al.International Journal of Biological Sciences|January 2, 2015
Integrative genomic and transcriptomic characterization of matched primary and metastatic liver and colorectal carcinomaStephanie Roessler, Guoling Lin, Marshonna Forgues, et al.Oncogenesis|December 28, 2022
LPA receptor 1 (LPAR1) is a novel interaction partner of Filamin A that promotes Filamin A phosphorylation, MRTF-A transcriptional activity and oncogene-induced senescenceAndreas Konopa, Melanie A Meier, Miriam J Franz, et al.Cancer Research|December 17, 2010
A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patientsStephanie Roessler, Hu-Liang Jia, Anuradha Budhu, et al.Hepatology (Baltimore, Md.)|January 25, 2022
Therapeutic efficacy of FASN inhibition in preclinical models of HCCHaichuan Wang, Yi Zhou, Hongwei Xu, et al.Pageof 12